Cryo-Cell International Inc (NYSEAMERICAN: CCEL) suffers from extremely meaningful negative changes in investment behavior: negative upside/downside volume developed, and the stock fell on very heavy volume. Recent significant negative changes in fundamentals have impacted Cryo-Cell […]
Canterbury Park Holding Corp (NASDAQ: CPHC) has reported E.P.S. of $-0.25 for its fourth fiscal quarter (ending December 31) versus $0.28 for the same period a year ago — a decline of -189%. E.P.S. were […]
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) stock suffered a major decline of -10.4% on 3/10/25. The shares closed at $15.21. NORMAL trading volume accompanied the decline. Relative to the market the stock has been weak over […]
Extremely significant negative changes in Trustmark Corp (NASDAQ: TRMK) investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, and its shorter term price trend turned down. Recent important negative […]
Tesla Inc (NASDAQ: TSLA) stock closed at $222.15 on 3/10/25 after a major decline of -15.4%. Moreover, exceptionally high trading volume at 221% of normal accompanied the decline. The stock has been exceptionally strong relative […]
RH (NYSE: RH) stock suffered a major decline of -11.1% on 3/10/25. The shares closed at $233.41. Moreover, exceptionally high trading volume at 245% of normal accompanied the decline. The stock has been exceptionally strong […]
Microchip Technology Inc (NASDAQ: MCHP) stock suffered a major decline of -10.6% on 3/10/25. The shares closed at $53.45. Moreover, trading volume in this decline was unusually high at 160% of normal. The stock has […]
Extremely significant negative changes in MBIA Inc. (NYSE: MBI) investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, its longer term price […]
Century Aluminum Co (NASDAQ: CENX) stock closed at $16.59 on 3/10/25 after a major decline of -11.1%. Moreover, this decline was accompanied by unusually high trading volume at 159% of normal. Relative to the market […]
Atara Biotherapeutics Inc (NASDAQ: ATRA) stock suffered a major decline of -10.7% on 3/10/25. The shares closed at $6.16. However, trading volume in this decline was unusually low at 58% of normal. The stock has […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research